Navigation Links
QuantaLife™ Kicks Off Droplet Digital™ PCR Road Show
Date:8/26/2011

PLEASANTON, Calif., Aug. 26, 2011 /PRNewswire/ -- QuantaLife, Inc., a pioneer in the area of digital PCR, is embarking on a seven-city tour to give scientists the opportunity to evaluate the capabilities of digital PCR and see the QuantaLife Droplet Digital PCR (ddPCR™) System in action. The tour will start on Monday, September 12 in Boston and finish up in San Francisco on Friday, September 23.

The QuantaLife ddPCR System claims to be the world's most precise quantitative PCR system. It introduces the next generation of PCR by providing absolute quantification of targeted nucleic acid molecules, a capability that could play a significant role in the development of companion diagnostics and the emergence of personalized medicine – a role that has long been held by real-time PCR.

The Droplet Digital PCR Road Show will take place at the following cities from September 12 through September 23:

  • Boston, MA: Monday, September 12
  • Potomac, MD: Tuesday, September 13
  • New York, NY: Friday, September 16
  • Chicago, IL: Monday, September 19
  • Seattle, WA: Tuesday, September 20
  • San Diego, CA: Wednesday, September 21
  • San Francisco, CA: Friday, September 23

The featured speaker is Dr. Jason H. Bielas of the Fred Hutchinson Cancer Research Center who will present his results from the use of the ddPCR system in the study of mutation detection in clinical samples. Breakout sessions will also be held on the use of ddPCR for sensitive detection of rare mutants, measurement of copy number, and gene expression.  A ddPCR system will be available for demonstration.

There is no charge for attendees. Details and registration information are available at www.QuantaLife.com or by calling (650) 823-6366. Space is limited, and early registration is strongly encouraged.

The QuantaLife Droplet Digital PCR system was introduced last November at the 60th Annual American Society of Human Genetics Meeting and was recognized recently with the 2011 North American Frost & Sullivan Award for New Product Innovation.

About QuantaLife

QuantaLife has developed the 3rd generation of PCR technology that quantifies DNA molecules by Droplet Digital™ PCR. Droplet Digital PCR provides an absolute measure of target molecules with unrivaled sensitivity and precision.  The company's mission is to provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.


'/>"/>
SOURCE QuantaLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BIOSCIENCE EAST, the Life Sciences Industry Map, Highlighting Global Leaders in Healthcare Innovation, Kicks Off 5th Edition
2. CarePoint Partners Kicks Off Food Drive to Help Fight Hunger in Twenty-One Local Communities
3. National Anesthesia Services Kicks Off 2010 Operation Iraq: The Spirit of Christmas Campaign With $10,000 Donation
4. Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
5. The AccuLift Phenomenon Kicks off on CBS The Early Show
6. ASPEX Kicks Off Free Send Us Your Sample Microscopy Campaign
7. American Lung Association of the Mid-Atlantic Kicks Off 2009-2010 Faces of Influenza Campaign in Philadelphia
8. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
9. Actress and Mother Jennifer Garner Kicks Off American Lung Associations Faces of Influenza Awareness Campaign, Encouraging Families to Get Vaccinated Against Influenza
10. QuantaLife, Inc. Receives Tax Credit for Development of Droplet Digital™ PCR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):